Researchers have devised an AI-driven approach to reprogram tumor-infiltrating immune cells, enhancing their ability to target and destroy cancer. This breakthrough offers fresh hope for more effective, personalized cancer immunotherapies.
Associate Professor Bryan Bryson at MIT is leading pioneering research to better understand how immune cells eradicate tuberculosis bacteria. Combining novel engineering and biological techniques, his lab aims to identify new vaccine targets and accelerate the development of more effective tuberculosis therapies—a crucial global health challenge still responsible for over a million deaths per year.
Stay informed with curated insights delivered weekly to your inbox.